MoonLake Immunotherapeutics (MLTX)

NASDAQ: MLTX · Real-Time Price · USD

16.20

+0.53 (3.38%)

Feb 2, 2026, 12:36 PM EST - Market open

MLTX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,156	3,415	3,620	409	-
Market Cap Growth	-58.30%	-5.66%	784.47%	-	-
Enterprise Value	866	2,932	3,189	353	-
Last Close Price	15.67	54.15	60.39	10.50	9.89
PB Ratio	3.46	7.53	7.05	5.95	-
P/TBV Ratio	4.05	7.64	7.30	8.37	-
Debt / Equity Ratio	0.26	0.01	0.01	0.00	-1.29
Quick Ratio	7.95	20.07	51.38	9.44	0.39
Current Ratio	8.50	21.11	51.59	9.98	0.46
Return on Equity (ROE)	-54.33%	-25.08%	-15.14%	-225.86%	-
Return on Assets (ROA)	-30.72%	-17.81%	-11.21%	-93.99%	-
Return on Capital Employed (ROCE)	-62.60%	-31.40%	-10.50%	-94.00%	300.70%
Earnings Yield	-17.98%	-3.48%	-1.00%	-12.21%	-
FCF Yield	-15.88%	-3.43%	-1.19%	-13.66%	-
Buyback Yield / Dilution	-1.82%	-27.99%	-67.30%	-274.47%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q